Delivery Order SPE2DB20D3505-SPE2DB25FU7T2
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg capsules of the drug lisdexamfetamine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price award with a ceiling value of $3,249.17 and a completion date of June 6, 2025. This award is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lisdexamfetamine 30 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $8,520.42 and a performance period extending through June 2025. This is a firm fixed-price contract without any set-aside...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,455.96, is for the delivery of 4,568,086,095 units of Lisdexamfetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 counts of 10 mg Lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $2,811.76 and a completion date of May 23, 2025. This contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,513.98 firm fixed-price contract is for the delivery of lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of January 28, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 20 mg capsules, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $6,122.59 and is a firm fixed-price contract with a period of performance ending on May 5, 2025. This contract is not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,033,529 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,976.17 and a performance period through April 28, 2025. Amerisourcebergen Drug Corp also holds a larger...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,699.29. The contract is for the delivery of Lisdexamfetamine 20 mg capsules in 100-count packages. This order is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,231.24, is for the supply of Lisdexamfetamine 50 mg capsules to support federal medical requirements. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...